Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer

Summary

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.

Eligibility

Inclusion Criteria:

* • 1.Age \>18 and \<80 years old

  * 2\. The pathological diagnosis was epithelial ovarian cancer
  * 3.Survival time is expected to exceed 3 months
  * 4.Signed consent form

Exclusion Criteria:

* 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function
* 2.Patients with a history of exhaustion or deep vein thrombosis;
* 3\. Liver insufficiency (transaminase \>2.5 times the upper limit of the standard);
* 4\. Renal insufficiency (serum muscle liver \>2 times the standard upper limit);
* 5\. Pregnancy and perinatal patients;
* 6\. History of major organ transplantation and immune disease;
* 7\. Psychiatric condition or language barriers
* 8\. Alcohol or drug abuser (current or previous)
* 9\. Unable or unwilling to sign informed consent or comply with study requirements;
* 10\. Patients with other malignant tumors.

Conditions2

Browse More Trials